Crohn’s Disease Study involving an investigational subcutaneous medication (PF-04236921)). Double-blind, placebo-controlled study.

Print

Details of Research

Contact: Shelley Mikolainis, Study Coordinator
E-mail: smikolainis@mtsinai.on.ca